‘I wouldn’t dare take these drugs’: how China supplies untested peptides to the west
The success of weight-loss drugs has driven demand for injectable compounds that claim to improve everything from sleep to skin
Related reading
US weight-loss biotech’s $600mn fund raise signals China’s role in drug trials
Clinical studies can be finished faster and cheaper than in US and provide an earlier sign of a drug’s potential
The race to launch a pill for weight loss
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of…
AstraZeneca strikes $4.7bn China deal to boost weight-loss drugs pipeline
Drugmaker expands push into fast-growing market
China to drive a weight-loss drug price war
The active ingredient semaglutide is starting to lose patent protection and China can produce GLP-1 related treatments at scale
Chinese drugmakers shift from copycats to global innovators
Reforms, faster development and lower costs have turbocharged growth
How one supplement sums up the uneasy science of selling youth
The potential anti-ageing effects of molecule spermidine have attracted longevity researchers and the wellness industry